Lung Cancer

In this video, Upal Basu Roy, PhD, MPH, spoke with Healio about “fantastic presentations” from this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this video, Upal Basu Roy, PhD, MPH, executive director of research at LUNGevity Foundation, discusses the role of air pollution in the rise of lung cancer incidence.

Healio spoke with Upal Basu Roy, PhD, MPH, about lung cancer clinical trials and the impact the COVID-19 pandemic had on enrollment.

In this video, Pasi A. Jänne, MD, PhD, director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School, discusses results from the IMpower010 study presented at ESMO 2021.

Use of an artificial intelligence program detected lung nodules up to 1 year before their detection by radiologists, researchers reported at the virtual European Respiratory Society International Congress.

In this video, Pasi A. Jänne, MD, PhD, director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School, discusses results from the DESTINY-Lung01 study presented at ESMO 2021.

Until the last decade, efforts to develop a therapy that successfully targeted the KRAS mutation had been futile.

In this video, Jae Y. Kim, MD, discusses various sessions from the International Association for the Study of Lung Cancer World Conference on Lung Cancer that highlighted global disparities.

Evaluation of multiple classifiers, both alone and in combination, supports the decision to focus on cell-free DNA methylation patterns to detect cancer and predict the cancer signal origin, according to a presentation at ESMO Congress 2021.

Patients with early-stage non-small cell lung cancer who received best supportive care vs. atezolizumab after adjuvant chemotherapy had a higher relapse rate, but relapse patterns appeared similar between the groups, study results showed.